| Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3 T Matsuda, T Yamamoto, A Muraguchi, F Saatcioglu Journal of Biological Chemistry 276 (46), 42908-42914, 2001 | 317 | 2001 |
| CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1 K Frønsdal, N Engedal, T Slagsvold, F Saatcioglu Journal of Biological Chemistry 273 (48), 31853-31859, 1998 | 296 | 1998 |
| Antiestrogenic Effects of 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin Are Mediated by Direct Transcriptional Interference with the Liganded Estrogen Receptor: CROSS-TALK BETWEEN … I Kharat, F Saatcioglu Journal of Biological Chemistry 271 (18), 10533-10537, 1996 | 272 | 1996 |
| Wellness through a comprehensive Yogic breathing program–A controlled pilot trial A Kjellgren, SÅ Bood, K Axelsson, T Norlander, F Saatcioglu BMC complementary and alternative medicine 7, 1-8, 2007 | 261 | 2007 |
| Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis KE Wellen, R Fucho, MF Gregor, M Furuhashi, C Morgan, T Lindstad, ... Cell 129 (3), 537-548, 2007 | 257 | 2007 |
| Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer … N Sato, MD Sadar, N Bruchovsky, F Saatcioglu, PS Rennie, S Sato, ... Journal of Biological Chemistry 272 (28), 17485-17494, 1997 | 245 | 1997 |
| IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling X Sheng, HZ Nenseth, S Qu, OF Kuzu, T Frahnow, L Simon, S Greene, ... Nature communications 10 (1), 323, 2019 | 194 | 2019 |
| Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double … B Lazarevic, G Boezelijn, LM Diep, K Kvernrod, O Ogren, H Ramberg, ... Nutrition and cancer 63 (6), 889-898, 2011 | 180 | 2011 |
| Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer CG Korkmaz, KS Korkmaz, P Kurys, C Elbi, L Wang, TI Klokk, ... Oncogene 24 (31), 4934-4945, 2005 | 153 | 2005 |
| Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity ME Ertunc, J Sikkeland, F Fenaroli, G Griffiths, MP Daniels, H Cao, ... Journal of lipid research 56 (2), 423-434, 2015 | 151 | 2015 |
| Rapid gene expression changes in peripheral blood lymphocytes upon practice of a comprehensive yoga program S Qu, SM Olafsrud, LA Meza-Zepeda, F Saatcioglu PloS one 8 (4), e61910, 2013 | 148 | 2013 |
| Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer Z Xi, TI Klokk, K Korkmaz, P Kurys, C Elbi, B Risberg, H Danielsen, ... Cancer research 64 (7), 2365-2370, 2004 | 142 | 2004 |
| Ligand-specific dynamics of the androgen receptor at its response element in living cells TI Klokk, P Kurys, C Elbi, AK Nagaich, A Hendarwanto, T Slagsvold, ... Molecular and cellular biology, 2007 | 140 | 2007 |
| Androgen signaling and its interactions with other signaling pathways in prostate cancer M Kaarbø, TI Klokk, F Saatcioglu Bioessays 29 (12), 1227-1238, 2007 | 137 | 2007 |
| Disrupted amino-and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity J Thompson, F Saatcioglu, OA Janne, JJ Palvimo Molecular endocrinology 15 (6), 923-935, 2001 | 137 | 2001 |
| Negative transcriptional regulation by nuclear receptors. F Saatcioglu, FX Claret, M Karin Seminars in cancer biology 5 (5), 347-359, 1994 | 134 | 1994 |
| Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ... Cell reports 19 (10), 2045-2059, 2017 | 131 | 2017 |
| A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation F Saatcioglu, T Deng, M Karin Cell 75 (6), 1095-1105, 1993 | 127 | 1993 |
| STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer L Wang, Y Jin, YJ Arnoldussen, I Jonson, S Qu, GM Mælandsmo, ... Cancer research 70 (14), 5818-5828, 2010 | 123 | 2010 |
| Cross-talk between bone morphogenic proteins and estrogen receptor signaling T Yamamoto, F Saatcioglu, T Matsuda Endocrinology 143 (7), 2635-2642, 2002 | 121 | 2002 |
